Funded Grants

PI Name Sort descending PI Organization Title Grant Number Initiative Program Official
Herrmann, Joerg

Mayo Clinic Rochester
United States

TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial 5R01CA233610-06 Eileen Dimond, R.N., M.S.
Hilakivi-Clarke, Leena A.

University Of Minnesota
United States

Effect of maternal obesity on breast cancer among offspring: role of the gut microbiota 5R01CA276775-02 Amit Kumar, Ph.D.
Hill, Joshua Aiden

Fred Hutchinson Cancer Center
United States

Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy 5R01CA276040-02 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Hirsch, Fred R

Icahn School Of Medicine At Mount Sinai
United States

Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses 3U54CA260560-02S3 Guillermo Marquez, Ph.D.
Hitchins, Megan P

Cedars-Sinai Medical Center
United States

Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age 5R01CA252042-04 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Matthew Young, Ph.D.
Hoffman, Amy Jude

University Of Nebraska Medical Center
United States

Managing Fatigue Using Virtual Reality for Post-Operative Lung Cancer Patients 5R01CA205025-06
Hofseth, Lorne J

University Of South Carolina At Columbia
United States

Harnessing the power of p53 with Panaxynol from American Ginseng to suppress colitis and prevent colon cancer 3R01CA246809-05S1 Marjorie Perloff, M.D.
Hollingsworth, Michael A.

University Of Nebraska Medical Center
United States

Pancreatic Cancer Detection Consortium 5U01CA210240-08 Matthew Young, Ph.D.
Hoshida, Yujin

Ut Southwestern Medical Center
United States

Epigallocatechin gallate for prevention of lethal cirrhosis complications 5R01CA282178-02 Asad Umar, D.V.M., Ph.D.
Hoshida, Yujin

Ut Southwestern Medical Center
United States

Therapeutic modulation of a proteomic HCC risk signature with statins in patients with liver cirrhosis 5U01CA288375-02 Matthew Young, Ph.D.